Sulfonylurea use associated with reduction in blood glucose levels during exercise stress testing.
Dasgupta
Kaberi
K
McGill University, Montreal, Quebec, Canada. Kaberi.Dasgupta@mcgill.ca
Grover
Steven A
SA
Lowensteyn
Ilka
I
Yale
Jean-Francois
JF
Da Costa
Deborah
D
Rahme
Elham
E
D000328:Adult; D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000187:drug effects* / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy* / Q000503:physiopathology; D005080:Exercise Test; D017079:Exercise Tolerance / Q000187:drug effects; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000097:blood / Q000188:drug therapy; D011237:Predictive Value of Tests; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D016896:Treatment Outcome
D015415:Biomarkers; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds